Taiwan Liposome Company Ltd ADR
(TLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TLC | HELP | RLMD | ||
| Company | Taiwan Liposome Company Ltd ADR | Cybin Inc | Relmada Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 7.00 | 6.56 | 4.02 | ||
| High | 7.09 | 6.65 | 4.02 | ||
| Low | 7.00 | 5.88 | 3.71 | ||
| Latest | 7.00 | 5.92 | 3.90 | ||
| Change | unch | -0.57 | -0.10 | ||
| % Change | unch | -8.78% | -2.50% | ||
| Volume | 12,400 | 481,000 | 287,600 | ||
| 20-Day Average Volume | 16,215 | 477,330 | 580,960 | ||
| Previous Close | 7.00 | 6.49 | 4.00 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.19 | 6.90 | 3.88 | ||
| 20-Day Raw Stochastic | 33.33% | 6.48% | 51.89% | ||
| 20-Day Relative Strength | 49.27 | 39.14 | 49.31 | ||
| Weighted Alpha | +41.19 | -36.44 | +230.68 | ||
| Today's Opinion | 56% Buy | 40% Sell | 56% Buy | ||
| Previous Opinion | 56% Buy | 24% Sell | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.79% since 09/21/21 | +1.02% since 02/05/26 | +8.33% since 02/05/26 | ||
| Low | 6.82 on 09/24/21 | 5.76 on 02/09/26 | 3.60 on 02/06/26 | ||
| High | 7.09 on 09/28/21 | 7.19 on 02/10/26 | 4.35 on 02/09/26 | ||
| 1-Month | |||||
| %Chg | -1.41% since 08/27/21 | -19.78% since 01/12/26 | -5.11% since 01/12/26 | ||
| Low | 6.65 on 09/17/21 | 5.76 on 02/09/26 | 3.22 on 02/04/26 | ||
| High | 7.70 on 09/02/21 | 8.23 on 01/15/26 | 4.53 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | +19.45% since 06/28/21 | -8.36% since 11/12/25 | -0.26% since 11/12/25 | ||
| Low | 5.70 on 07/02/21 | 5.50 on 12/02/25 | 3.22 on 02/04/26 | ||
| High | 7.70 on 09/02/21 | 9.12 on 12/30/25 | 5.12 on 11/19/25 | ||
| 6-Month | |||||
| %Chg | +28.44% since 03/26/21 | -22.41% since 08/12/25 | +563.27% since 08/12/25 | ||
| Low | 4.16 on 05/21/21 | 5.50 on 12/02/25 | 0.56 on 08/13/25 | ||
| High | 7.70 on 09/02/21 | 9.12 on 12/30/25 | 5.12 on 11/19/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 294,539 | 295,372 | 286,003 | ||
| Shares Outstanding, K | 42,077 | 49,894 | 73,334 | ||
| Annual Sales | 3,630,000 | 0 | 0 | ||
| Annual Net Income | -35,020,000 | -81,310,000 | -79,980,000 | ||
| Last Quarter Sales | 5,730,000 | 0 | 0 | ||
| Last Quarter Net Income | -1,990,000 | -33,720,000 | -10,090,000 | ||
| 60-Month Beta | 0.99 | 0.63 | 0.76 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/12/21 | -1.39 on 11/13/25 | -0.30 on 11/13/25 | ||
| Latest Earnings Date | 10/27/21 | 02/16/26 | 03/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||